Who are the key players in North America Autoimmune Disease Diagnosis Market industry?

The top five key players include Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, Siemens Healthineers, and F. Hoffmann-La Roche AG. These companies are prominent due to their advanced diagnostic technologies, extensive product portfolios, and significant market presence, driving innovation and competition in the North American autoimmune disease diagnostics landscape.

Which segment accounted for the largest North America Autoimmune Disease Diagnosis Market share?

The systemic autoimmune disease application segment holds the largest market share, primarily due to the high incidence of conditions such as rheumatoid arthritis and systemic lupus erythematosus. Advanced diagnostic tools and increased awareness have fueled the adoption of testing procedures in this segment, leading to continued dominance.

What are the factors driving the North America Autoimmune Disease Diagnosis Market?

Key factors include the rising prevalence of autoimmune diseases, increased healthcare expenditure, and advancements in diagnostic technologies. For example, Thermo Fisher Scientific’s launch of novel autoantibody detection kits has accelerated early diagnosis, improving patient outcomes and boosting market growth across North America.

Which type accounted for the largest North America Autoimmune Disease Diagnosis Market share?

The consumables and assay kits segment captures the largest market share. Their essential role in high-frequency laboratory testing for autoimmune diseases, combined with the regular need for replenishment, ensures steady demand. Innovations in assay kit sensitivity and specificity further cement their leading position in the market.

Home Healthcare

North America Autoimmune Disease Diagnosis Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Q: What is the North America Autoimmune Disease Diagnosis Market growth?

The North America Autoimmune Disease Diagnosis Market is experiencing robust growth, with a CAGR of over 8% in recent years. Abbott Laboratories, for instance, has reported increased demand for its advanced immunology and diagnostic solutions, driven by rising autoimmune disorder prevalence and advancements in laboratory automation.

North America Autoimmune Disease Diagnosis Market: by Type (Systemic Autoimmune Disease, Localized Autoimmune Disease), Application (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Thyroiditis, Multiple Sclerosis, Type 1 Diabetes, Others), Distribution Channels (Hospital-based Laboratories, Independent Laboratories, Research Institutes, Others), Technology (ELISA, Immunoassays, Chemiluminescence Assay, Immunofluorescence Assay, Western Blotting, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20406

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	6410
Regions	North America (US, Canada, Mexico)
Segments	By Type: Systemic Autoimmune Disease, Localized Autoimmune Disease, Auto-inflammatory Diseases, Endocrine Autoimmune Disease, Gastrointestinal Autoimmune Disease, Other Types; By Application: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Thyroiditis, Multiple Sclerosis, Type 1 Diabetes, Other Applications
Players	Abbott Laboratories, Siemens Healthineers, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Werfen, Quest Diagnostics, bioMérieux SA, Trinity Biotech plc, EUROIMMUN (PerkinElmer), Grifols, S.A., Hologic, Inc., ZEUS Scientific, Inc., SQI Diagnostics

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	6410
Regions	North America (US, Canada, Mexico)
Segments	By Type: Systemic Autoimmune Disease, Localized Autoimmune Disease, Auto-inflammatory Diseases, Endocrine Autoimmune Disease, Gastrointestinal Autoimmune Disease, Other Types; By Application: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Thyroiditis, Multiple Sclerosis, Type 1 Diabetes, Other Applications
Players	Abbott Laboratories, Siemens Healthineers, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Werfen, Quest Diagnostics, bioMérieux SA, Trinity Biotech plc, EUROIMMUN (PerkinElmer), Grifols, S.A., Hologic, Inc., ZEUS Scientific, Inc., SQI Diagnostics